Latest News
Via The Motley Fool · May 12, 2025
Via The Motley Fool · May 12, 2025
Business automation software provider Upland Software (NASDAQ: UPLD) beat Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 10% year on year to $63.66 million. On the other hand, next quarter’s revenue guidance of $53.3 million was less impressive, coming in 11.7% below analysts’ estimates. Its non-GAAP profit of $0.23 per share was 32.7% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
It's still unclear how President Donald Trump plans to tie drug prices in the U.S. to international prices.
Via Investor's Business Daily · May 12, 2025
Bitcoin resumes its bullish cycle within the final 5th Wave from a technical point of view and by Elliott wave theory.
Via Talk Markets · May 12, 2025
Since President Donald Trump’s ‘Liberation Day’ tariff announcements on April 2, Amazon’s stock has gained 13%, and Tesla’s shares have climbed 18%.
Via Stocktwits · May 12, 2025
The price of a troy ounce of gold fell to 3,273 USD on Monday, losing about 1% compared to the previous session’s level.
Via Talk Markets · May 12, 2025
Hospital operator HCA Healthcare (NYSE:HCA) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 5.7% year on year to $18.32 billion. The company expects the full year’s revenue to be around $74.3 billion, close to analysts’ estimates. Its GAAP profit of $6.45 per share was 11.5% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Robinhood and SoFi Technologies are still sound long-term investments.
Via The Motley Fool · May 12, 2025
Given the importance of the Fed balance sheet, let’s dive into the stealth QE accusation and uncover the facts.
Via Talk Markets · May 12, 2025
Cable, internet, and telephone services provider Charter (NASDAQ:CHTR) met Wall Street’s revenue expectations in Q1 CY2025, but sales were flat year on year at $13.74 billion. Its non-GAAP profit of $8.42 per share was 2% below analysts’ consensus estimates.
Via StockStory · May 12, 2025
Via The Motley Fool · May 12, 2025
Life sciences company Avantor (NYSE:AVTR) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 5.9% year on year to $1.58 billion. Its non-GAAP profit of $0.23 per share was in line with analysts’ consensus estimates.
Via StockStory · May 12, 2025
Shares of XPeng surged 7.7% Monday morning. The U.S. and China reached a temporary truce in their ongoing trade dispute.
Via Benzinga · May 12, 2025
Children’s apparel manufacturer Carter’s (NYSE:CRI) announced better-than-expected revenue in Q1 CY2025, but sales fell by 4.8% year on year to $629.8 million. Its non-GAAP profit of $0.66 per share was 27.8% above analysts’ consensus estimates.
Via StockStory · May 12, 2025

The S&P 500 retreated a half percent from its previous week's close, ending the trading week at 5,659.91.
Via Talk Markets · May 12, 2025
A fundamental analysis of (NASDAQ:PYPL): Exploring PAYPAL HOLDINGS INC (NASDAQ:PYPL)'s quality characteristics.
Via Chartmill · May 12, 2025
Health coverage company Centene (NYSE:CNC) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 15.4% year on year to $46.62 billion. The company’s full-year revenue guidance of $180 billion at the midpoint came in 4.2% above analysts’ estimates. Its non-GAAP profit of $2.90 per share was 15.3% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Electronic system and device provider Bel Fuse (NASDAQ:BELFA) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 18.9% year on year to $152.2 million. Its GAAP profit of $1.36 per share was 64.8% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Health care services provider Encompass Health (NYSE:EHC) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 10.6% year on year to $1.46 billion. The company’s full-year revenue guidance of $5.89 billion at the midpoint came in 0.5% above analysts’ estimates. Its non-GAAP profit of $1.37 per share was 15% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Via Benzinga · May 12, 2025
In the face of ongoing trade tensions, Apple Inc. (NASDAQ: AAPL) is reportedly contemplating raising the prices for its forthcoming fall iPhone models, while also planning to introduce new features and design changes.
Via Benzinga · May 12, 2025
Novo Nordisk reports phase 3 data showing weekly Sogroya matched or outperformed daily hormone therapy in multiple pediatric growth disorders.
Via Benzinga · May 12, 2025